Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody
{{output}}
Antibody-epitope conjugates (AECs) proved to be a promising new therapeutic strategy to redirect virus-specific CD8+ T cells toward cancer cells by delivering T-cell epitopes. To be able to redirect a larger fraction of the virus-specific T-cell population, it... ...
